With New Hires to Pharma Business Development Team, Qiagen Prioritizes Rx/Dx Partnership Strategy

Although Qiagen is prioritizing Rx/Dx partnerships with pharma, that doesn't mean it won't look into bringing tests to market with payors or on its own.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.